Dottikon ES Holding AG (LON:0ACK)

Market Cap	4.79B +103.2%
Revenue (ttm)	403.91M +28.3%
Net Income	112.86M +60.2%
EPS	8.17 +60.2%
Shares Out	n/a
PE Ratio	42.42
Forward PE	43.39
Dividend	n/a
Ex-Dividend Date	n/a

Volume	138
Average Volume	671
Open	365.50
Previous Close	363.46
Day's Range	364.21 - 365.50
52-Week Range	203.50 - 384.50
Beta	0.97
RSI	65.17
Earnings Date	May 29, 2026

About Dottikon ES Holding AG

Dottikon ES Holding AG manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical maceutic industries in Europe, Switzerland, the United States, and Asia. The company’s chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blocks, chiral compounds, cyclohexane derivatives, cyclopropyl building blocks, indazoles, indoles, N-heterocycles, nitrate esters, nitroaromatic compound...

• Industry: Industrial Organic Chemicals
• Founded: 1913
• Employees: 875
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0ACK

Financial Performance

In fiscal year 2025, Dottikon ES Holding AG's revenue was 392.68 million, an increase of 17.93% compared to the previous year's 332.98 million. Earnings were 105.58 million, an increase of 30.95%.

Financial numbers in CHF